A type of drug made for cancer treatment may be promising for neurodegenerative disorders such as Alzheimer’s disease (AD). Research led by Pennsylvania State and Stanford Universities found that blocking the indoleamine-2,3-dioxygenase 1 (IDO1) enzyme in mice models of AD restored metabolism in brain astrocytes, rescuing memory and brain function. Now, the IDO1 inhibitors being developed to treat cancer may be repurposed for early treatment of AD and other neurodegenerative diseases.
UK retailer Co-Op says systems now running normally after cyber incident – CNA
UK retailer Co-Op has announced that its systems are functioning normally following a recent cyber incident. The company experienced disruptions but has resolved the issues
